Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinopharm Guorui Pharmaceutical is a prominent subsidiary of Sinopharm Modern Pharmaceutical Co., Ltd., specializing in the development and large-scale production of finished dosage forms and active pharmaceutical ingredients (APIs). Based in Huainan, China, the company operates advanced GMP-certified facilities that produce a diverse range of products, including lyophilized powders for injection, tablets, and capsules. Its core therapeutic focus areas include anti-infectives, cardiovascular health, and digestive system medications. As a key industrial unit within the China National Pharmaceutical Group (Sinopharm), the company serves as a major production base for cephalosporin antibiotics. Sinopharm Guorui is recognized for its strong manufacturing capabilities and its role in both domestic supply and international pharmaceutical exports.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sinopharm Guorui Pharmaceutical.